Tazeen Ahmad
BofA Securities, Research Division

I'm Tazeen Ahmad. I'm one of the senior biotech analysts here at the bank. It's my pleasure to have our next presenting company, Amgen. Sitting up on stage, our several members from the Amgen team. Thanks in advance for making the trip over from California. We really appreciate it.

So we have Peter Griffith, who is Executive Vice President and CFO; we have Jay Bradner, who's Executive President of Research and Development; and then we, of course, have Casey Capparelli, who is Vice President, Investor Relations. Gentlemen, thank you for making the trip again.

James Bradner
Executive Vice President of Research & Development

Thank you for having us.

Tazeen Ahmad
BofA Securities, Research Division

Okay. So maybe we could do a quick overview of the company and some important comments that you -- or statements that you need to make before we go into more detail. So I'll turn it over to Peter for that.

Peter Griffith
Executive VP & CFO

Great. Tazeen, thank you. Good morning, everyone. I would just add, coming over to Las Vegas is there's traffic coming over. But in today's world, there's a lot less going back. So we'll take advantage of that. So thank you for having us. We are glad to be here.

I've got a few prepared remarks I just want to run through and cover before we go to Q&A. We believe, first of all, there are a lot of ways for us to win. And